Authors: Nilsberth, C Westlind-Danielsson, A Eckman, CB Condron, MM Axelman, K Forsell, C Stenh, C Luthman, J Teplow, DB Younkin, SG Naslund, J Lannfelt, L

Citation: C. Nilsberth et al., The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation, NAT NEUROSC, 4(9), 2001, pp. 887-893

Authors: Luthman, J

Citation: J. Luthman, The kynurenine pathway of tryptophan degradation as a target for neuroprotective therapies - Introduction, AMINO ACIDS, 19(1), 2000, pp. 273-274

Authors: Luthman, J

Citation: J. Luthman, Anticonvulsant effects of the 3-hydroxyanthranilic acid dioxygenase inhibitor NCR-631, AMINO ACIDS, 19(1), 2000, pp. 325-334

Authors: Linderberg, M Hellberg, S Bjork, S Gotthammar, B Hogberg, T Persson, K Schwarcz, R Luthman, J Johansson, R

Citation: M. Linderberg et al., Synthesis and QSAR of substituted 3-hydroxyranthranilic acid derivatives as inhibitors of 3-hydroxyanthranilic acid dioxygenase (3-HAO), EUR J MED C, 34(9), 1999, pp. 729-744

Authors: Nilsberth, C Luthman, J Lannfelt, L Schultzberg, M

Citation: C. Nilsberth et al., Expression of presenilin 1 mRNA in rat peripheral organs and brain, HISTOCHEM J, 31(8), 1999, pp. 515-523

Authors: Fornstedt-Wallin, B Lundstrom, J Fredriksson, G Schwarcz, R Luthman, J

Citation: B. Fornstedt-wallin et al., 3-hydroxyanthranilic acid accumulation following administration of the 3-hydroxyanthranilic acid 3,4-dioxygenase inhibitor NCR-631, EUR J PHARM, 386(1), 1999, pp. 15-24